[1] You W, Yang J, Wang L, et al. Case report: a Chinese family of type A insulin resistance syndrome with diabetes mellitus, with a novel heterozygous missense mutation of the insulin receptor gene[J]. Front Endocrinol (Lausanne), 2022, 13: 895424.doi:10.3389/fendo.2022.895424. [2] Kido Y, Nakae J, Accili D. Clinical review 125: the insulin receptor and its cellular targets[J]. J Clin Endocrinol Metab, 2001, 86: 972-979. [3] Zhao L, Dai H, Zhang Q, et al. Identification of a novel mutation in patients with type A insulin resistance syndrome[J]. Hum Hered, 2022.doi:10.1159/000525223. [4] Vambergue A, Lautier C, Valat AS, et al. Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report[J]. Hum Reprod, 2006, 21: 1274-1278. [5] Preumont V, Feincoeur C, Lascols O, et al. Hypoglycae-mia revealing heterozygous insulin receptor mutations[J]. Diabetes Metab, 2017, 43: 95-96. [6] Mukherjee S, Maitra A. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome[J]. Indian J Med Res, 2010, 131: 743-760. [7] Nagashima S, Wakabayashi T, Saito N, et al. Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome[J]. J Diabetes Investig, 2020, 11: 1363-1365. [8] Horikawa O, Ugi S, Takayoshi T, et al. A family with type A insulin resistance syndrome caused by a novel insulin receptor mutation[J]. Endocrinol Diabetes Metab Case Rep, 2023, 2023.doi:10.1530/edm-22-0362. [9] Takasawa K, Tsuji-Hosokawa A, Takishima S, et al. Clinical characteristics of adolescent cases with type A insulin resistance syndrome caused by heterozygous muta-tions in the β-subunit of the insulin receptor (INSR) gene[J]. J Diabetes, 2019, 11: 46-54. [10] Martínez-Montoro JI, Pinzón-Martín JL, Damas-Fuentes M, et al.Combination therapy with semaglutide and dapagliflozin as an effective approach for the management of type a insulin resistance syndrome: a case report[J]. Front Endocrinol (Lausanne), 2022, 13: 838887.doi:10.3389/fendo.2022.838887. [11] 庞璨, 黄知敏, 朱慧丽, 等. 中国人A型胰岛素抵抗家系与胰岛素受体基因突变研究[J]. 中华内分泌代谢杂志, 2005, 21: 237-239. [12] 赵文蕊, 杨国庆. A型胰岛素抵抗综合征诊疗分析[J].实用医学杂志, 2013, 29: 4131-4132. [13] 黄知敏, 李延兵, 陈蔼玲, 等. A型胰岛素抵抗综合征胰岛素分泌变化的七年随访[J].中华内科杂志, 2011, 50: 10-13. [14] 薛忠光, 王圣祥, 周慧娟. 一例A型胰岛素抵抗合并癫痫患者的临床特征及遗传学分析[J].山东医学高等专科学校学报[J] , 2022, 44: 239-240+156. [15] Takeuchi T, Ishigaki Y, Hirota Y, et al. Clinical characteristics of insulin resistance syndromes: a nationwide survey in Japan[J]. J Diabetes Investig, 2020, 11: 603-616. |